Literature DB >> 15494780

Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management.

Colleen M Norris1, L Duncan Saunders, William A Ghali, Rollin Brant, P Diane Galbraith, Michelle Graham, Peter Faris, Vladimir Dzavik, Merril L Knudtson.   

Abstract

BACKGROUND: Given the repeated findings of little or no difference in mortality outcomes between percutaneous coronary intervention (PCI) with or without stent and coronary artery bypass graft surgery (CABG), there is a need to assess the health-related quality of life (HRQOL) outcomes associated with revascularization decisions.
OBJECTIVE: To compare risk-adjusted HRQOL outcomes by treatment strategy one year following cardiac catheterization.
METHODS: Using an inception cohort study design, the sample included all Alberta residents, 18 years of age or older, referred for cardiac catheterization, from January 1, 1996, to December 31, 1998, with two or more diseased coronary vessels at catheterization. Patients received a follow-up questionnaire including the Seattle Angina Questionnaire (SAQ), one year following their index catheterization. The SAQ comprises five dimensional scales measuring exertional capacity, anginal stability, anginal frequency, treatment satisfaction and quality of life.
RESULTS: Three thousand three hundred ninety-two (78.1%) patients responded to the follow-up survey. Responders who were revascularized consistently reported significantly better HRQOL compared with responders treated with medical management. Responders undergoing CABG reported significantly better HRQOL in all but one SAQ dimension compared with responders who had either a PCI with or without stent. Responders who had a PCI with stent reported better HRQOL compared with responders who underwent a PCI without a stent.
CONCLUSION: The treatment decision to revascularize the coronary vessels, whether with PCI with or without a stent or with CABG, was consistently associated with significantly better HRQOL at one-year follow-up compared with patients treated with medical therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15494780

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  12 in total

Review 1.  Optimising diagnostic accuracy with the exercise ECG: opportunities for women and men with stable ischaemic heart disease.

Authors:  Leslee J Shaw; Joe X Xie; Lawrence M Phillips; Abhinav Goyal; Harmony R Reynolds; Daniel S Berman; Michael H Picard; Balram Bhargava; Gerard Devlin; Bernard R Chaitman
Journal:  Heart Asia       Date:  2016-06-01

2.  Symptom expression in coronary heart disease and revascularization recommendations for black and white patients.

Authors:  Marilyn Hravnak; Jeff Whittle; Mary E Kelley; Susan Sereika; Chester B Good; Said A Ibrahim; Joseph Conigliaro
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

3.  Health-related quality of life: The impact of diagnostic angiography.

Authors:  Jo-Ann Eastwood; Lynn V Doering; Kathleen Dracup; Lorraine Evangelista; Ron D Hays
Journal:  Heart Lung       Date:  2010-08-06       Impact factor: 2.210

4.  Measurement invariance of the Seattle Angina Questionnaire in coronary artery disease.

Authors:  Oluwaseyi A Lawal; Oluwagbohunmi Awosoga; Maria J Santana; Matthew T James; Stephen B Wilton; Colleen M Norris; Lisa M Lix; Tolulope T Sajobi
Journal:  Qual Life Res       Date:  2021-09-08       Impact factor: 4.147

5.  Association between quality of life and mental stress-induced myocardial ischaemia in high-risk patients after coronary revascularization.

Authors:  Nan Nan; Wei Dong; Bingyu Gao; Feihuan Cui; Zhi Chang; Jian Jiao; Huijuan Zuo; Hongzhi Mi; Xiantao Song; Shuzheng Lyu; Hongjia Zhang
Journal:  Health Qual Life Outcomes       Date:  2022-04-26       Impact factor: 3.077

Review 6.  Quality-of-Life measures for cardiac surgery practice and research: a review and primer.

Authors:  Phillip J Tully
Journal:  J Extra Corpor Technol       Date:  2013-03

7.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Authors:  Ajay J Kirtane; Darshan Doshi; Martin B Leon; John M Lasala; E Magnus Ohman; William W O'Neill; Adhir Shroff; Mauricio G Cohen; Igor F Palacios; Nirat Beohar; Nir Uriel; Navin K Kapur; Dimitri Karmpaliotis; William Lombardi; George D Dangas; Manish A Parikh; Gregg W Stone; Jeffrey W Moses
Journal:  Circulation       Date:  2016-08-02       Impact factor: 39.918

8.  Impact of invasive treatment strategy on health-related quality of life six months after non-ST-elevation acute coronary syndrome.

Authors:  Li-Xia Yang; Yu-Jie Zhou; Zhi-Jian Wang; Yue-Ping Li; Meng Chai
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

9.  Sex differences in the quality of life of patients with acute coronary syndrome treated with percutaneous coronary intervention after a 3-year follow-up.

Authors:  Beata Jankowska-Polańska; Izabella Uchmanowicz; Krzysztof Dudek; Krystyna Łoboz-Grudzień
Journal:  Patient Prefer Adherence       Date:  2016-07-20       Impact factor: 2.711

10.  Drug-eluting coronary stents - focus on improved patient outcomes.

Authors:  Zehra Jaffery; Amit Prasad; John H Lee; Christopher J White
Journal:  Patient Relat Outcome Meas       Date:  2011-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.